About Immunetics
Immunetics is a company based in Boston (United States) founded in 1987 was acquired by Oxford Immunotec in October 2016.. Immunetics has raised $1.46 million across 34 funding rounds from investors including NIH, HHS and Oxford Immunotec.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Immunetics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.46 M (USD)
in 34 rounds
-
Latest Funding Round
$1.99 M (USD), Grant
Apr 01, 2015
-
Investors
NIH
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Oxford Immunotec
(Oct 12, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Immunetics
Immunetics has successfully raised a total of $1.46M across 34 strategic funding rounds. The most recent funding activity was a Grant round of $1.99 million completed in April 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 34
- Last Round Grant — $2.0M
-
First Round
First Round
(15 Sep 2000)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2015 | Amount | Grant - Immunetics | Valuation |
investors |
|
| Jul, 2014 | Amount | Grant - Immunetics | Valuation |
investors |
|
| Mar, 2014 | Amount | Private Equity Round - Immunetics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Immunetics
Immunetics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Oxford Immunotec. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences innovation is supported through funding and programs.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Immunetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Immunetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Immunetics Comparisons
Competitors of Immunetics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Immunetics
When was Immunetics founded?
Immunetics was founded in 1987 and raised its 1st funding round 13 years after it was founded.
Where is Immunetics located?
Immunetics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Immunetics a funded company?
Immunetics is a funded company, having raised a total of $1.46M across 34 funding rounds to date. The company's 1st funding round was a Private Equity Round of $835K, raised on Sep 15, 2000.
What does Immunetics do?
Immunetics, Inc., a biotechnology company, researches and develops immunoassay and molecular probe kits and instruments for the diagnosis of infectious diseases. Its products include Miniblotter instrument system for western blot, spoligotyping, and various multi-probe membrane assays; cell adhesion flow chamber for cell-cell interaction studies; and C6 peptide Lyme ELISA, a synthetic peptide ELISA test for Lyme disease anthrax. The companyâs products also include QuickELISA, a blood test for anthrax infection; and QualiCode western blot assays for diseases where diagnosis is challenging. In addition, it offers QuickELISA Anthrax-PA kit, an in vitro diagnostic test for the detection of antibodies to protective antigen of anthrax in human and animal samples; and BacTx Test for the bacterial contamination of platelets. The company sells its products through distributors in Belgium, Denmark, Norway, Finland, Sweden, France, Germany, Italy, the Netherlands, Switzerland, the United Kingdom, Canada, Honduras, Brazil, Ecuador, Venezuela, Australia, China, Korea, and Taiwan. Immunetics, Inc. was founded in 1987 and is based in Boston, Massachusetts.
Who are Immunetics's investors?
Immunetics has 6 investors. Key investors include NIH, HHS, Oxford Immunotec, SBIR, and Massachusetts Life Sciences Center.